Tigermed (300347.SZ) announced that as of November 30, 2024, the company's dedicated securities account for stock repurchase has cumulatively repurchased 3.6552 million shares through centralized bidding trade, accounting for 0.4226% of the total share capital of the company and 0.4927% of the total A-share capital of the company. The highest fill price was 55.30 yuan/share, the lowest fill price was 48.17 yuan/share, and the total transaction amount was 0.191 billion yuan (excluding transaction fees).
泰格医药:累计回购365.52万股 耗资1.91亿元
Tigermed: Cumulative repurchase of 3.6552 million shares, costing 0.191 billion yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.